Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 1(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07419854Phase 4Recruiting

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

Role: lead

NCT06604832Phase 1Completed

Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

Role: lead

NCT05885035Phase 1Completed

Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks

Role: lead

All 3 trials loaded